14, Oct 2026
Affibody Highlights Progress Across Radiopharmaceutical Pipeline at EANM 2026
Stockholm, Sweden, October 14, 2026. Affibody AB (“Affibody”) today announced a series of presentations at the 2026 Congress of the European Association of Nuclear Medicine (EANM), taking place October 17-21 in Vienna.
The presentations span both clinical and preclinical research and include results from the ongoing Phase I study with the Radioligand Therapy (RLT) candidate ABY-271 in HER2-positive metastatic breast cancer, clinical data with the HER2 PET imaging agent tezatabep matraxetan, and preclinical findings with Affibody molecules targeting B7-H3. Together, the presentations highlight the breadth of Affibody’s capabilities across targeted RLTs and precision imaging.
“The wealth and diversity of results being presented at EANM, one of the world’s leading congresses in nuclear medicine and theranostics, reflects both the potential of our Affibody technology and the strength of our collaborations,” said David Bejker, Chief Executive Officer of Affibody. “We are excited to see our science translate into meaningful advancements with the aim to address significant unmet needs in patients with hard-to-treat cancers.”
Presentations
Title: A First-in-Human Phase 1 Trial Safety and Biodistribution of [¹⁷⁷Lu]Lu-ABY-271 in Subjects with HER2-Positive Metastatic Breast Cancer (NCT07081555)
Presenter: Joachim Feldwisch, Affibody
Session: C: Therapy Clinical Study – C1 Oncological Therapy Clinical Study – C16 Other Oncological Treatments
Format: e-Poster
Presentation ID: EP-0981
Title: Whole-body HER2 PET/CT reveals spatial heterogeneity of HER2 expression in advanced gastroesophageal adenocarcinoma.
Presenter: Antonios Tzortzakakis, Karolinska Institutet
Date and Time: October 18, 2026, 08:00 CEST
Session: Clinical Oncology Track: Gastro-Intestinal Malignancy
Format: Oral
Presentation ID: OP-035
Title: Standardization of image quality and activity quantification in a multi-centre PET imaging study (Ex-PET)
Presenter: Jakob Lagerstedt, Karolinska University Hospital
Date and Time: October 20, 2026, 16:45 CEST
Session: Cutting Edge Science Track: Physics Committee: Quantitative PET:
Harmonisation and Robustness
Format: Oral
Presentation ID: OP-734
Title: Preclinical Evaluation of PNABased Affibody-mediated Pretargeting for targeting HER2: A direct comparison between Tb-161 and Lu-177
Presenter: Maryam Oroujeni, Uppsala University
Date and Time: October 18, 2026, 09:45 CEST
Session: M2M Track: TROP Session – Radiopharmaceutical Sciences Committee: 161Tb vs 177Lu, and The Winner Is…
Format: Oral
Presentation ID: OP-084
Title: Modular Molecular Design of B7H3Targeting Affibody Molecules for Radionuclide Therapy: Biodistribution-Driven Selection and Therapy
Presenter: Maryam Oroujeni, Uppsala University
Date and Time: October 20, 2026, 16:45 CEST
Session: Radiopharmaceutical Sciences Committee: Modern Approaches to Drug Development in Nuclear Medicine
Format: Oral e-Poster
Presentation ID: EPS-223
Title: HER2-Ex PET trial: A multicentre, prospective, open-label study using [68Ga]Ga-ABY-025 PET-imaging to characterize HER2-expression and explore the therapy-predictive value for HER2 antibody-drug conjugates in patients with metastatic breast cancer.
Presenter: Anna Kistner, Karolinska Institutet
Session: B: Imaging Clinical Studies – B1 Oncological Imaging Clinical Study – B13 Breast
Format: e-Poster
Presentation ID: EP-0261
Title: In vitro evaluation of Affibody molecules targeting B7-H3 for radionuclide therapy of neuroblastoma
Presenter: Maryam Oroujeni, Uppsala University
Session: A: Preclinical and Translational Studies – A1 Medical Preclinical – A11 In Vitro Studies
Format: e-Poster
Presentation ID: EP-0003
Title: Optimized Affibody Molecule targeting B7-H3 immune checkpoint: Improved Tumor Targeting Properties in a Syngeneic MC38 Model
Presenter: Enrique Recasens Pérez-Vera, Uppsala University
Session: A: Preclinical and Translational Studies – A1 Medical Preclinical – A18 New Radiopharmaceuticals – Therapy
Format: e-Poster
Presentation ID: EP-0171
Title: Feasibility of affibody-based pretargeted delivery of 225Ac
Presenter: Vladimir Tolmachev, Uppsala University
Session: A: Preclinical and Translational Studies – A1 Medical Preclinical – A18 New Radiopharmaceuticals – Therapy
Format: e-Poster
Presentation ID: EP-0161
Title: Biodistribution and dosimetry for PET imaging of HER2-receptor expression using [18F]-HER2 in metastatic breast cancer
Presenter: Ulrika Estenberg, Karolinska University Hospital
Session: B: Imaging Clinical Studies – B10 Dosimetry in Diagnostic Applications – B101 Dosimetry in Diagnostic Applications
Format: e-Poster
Presentation ID: EP-0617
View the EANM abstracts here: https://eanm26.eanm.org/
- 0
- By Neel Achary
14, Oct 2026
Continuity Biosciences Awarded $9.6 Million Grant to Advance Ultra-Long-Acting Implant for HIV Prevention
Funding supports development of a subcutaneous implant designed to deliver HIV prevention medicine for multiple years from a single placement, advancing toward an IND submission and initiation of a first-in-human Phase 1 study
BRADENTON, Fla. and SEATTLE, Oct. 14, 2026 /PRNewswire/ — Continuity Biosciences, LLC, a clinical-stage biotechnology company developing precision drug delivery platforms, today announced it has been awarded an up to $9.6 million grant from the Gates Foundation to advance a subcutaneous, ultra-long-acting antiretroviral (ARV) implant for HIV pre-exposure prophylaxis (PrEP) in low- and middle-income countries (LMICs).

The implant is designed to deliver HIV prevention medicine continuously for multiple years after a single insertion under the skin. It is intended as an alternative to daily oral pills and to periodic injections, giving people at risk of HIV a prevention option that requires fewer dosing decisions and clinic visits.
The grant will support development of Continuity’s ultra-long-acting ARV implant through Investigational New Drug (IND)-enabling studies, submission of an IND application, and initiation of a Phase 1 first-in-human clinical study.
“For many people, the challenge in HIV prevention is not the availability of effective medicines, but the burden of staying protected consistently over time,” said Ramakrishna “Krishna” Venugopalan, PhD, MBA, Co-Founder and Chief Executive Officer of Continuity Biosciences. “A prevention option designed to provide protection for years could fundamentally change what is possible, particularly in communities where access to healthcare is limited.
Despite major advances in prevention, there were 1.2 million new HIV infections in 2025, according to UNAIDS. Daily oral PrEP is highly effective when taken as prescribed, but sustaining adherence remains difficult for many people. Long-acting injectables have extended dosing intervals, yet still require regular clinic visits bi-monthly or bi-yearly currently, and a dependable supply chain. These challenges are even greater in low- and middle-income countries.
Continuity’s implant builds on the company’s nanofluidic drug delivery technology, which uses precisely engineered channels to control drug release at a steady rate over an extended period. The approach is designed to sustain protective drug exposure over time while reducing the need for repeat dosing.
“Our nanofluidic implant was engineered around a simple idea: HIV prevention shouldn’t depend on remembering a daily pill or the next appointment,” said Alessandro Grattoni, PhD, Co-Founder and Chief Scientific Advisor of Continuity Biosciences. “By controlling drug release at the device level, we aim to sustain constant ARV delivery for multiple years from a single implant. This support allows us to move that science from the laboratory toward a first-in-human evaluation.”
As part of the grant, Continuity has made Global Access commitments to the Gates Foundation, including making the resulting technology available at an affordable price to people most in need in low- and middle-income countries and broadly sharing knowledge gained from the program.
Beyond HIV prevention, Continuity is applying its precision delivery platforms across type 1 diabetes, endocrinology, and oncology, including an ongoing first-in-human study of its iontophoretic oncology platform in pancreatic cancer.
About Continuity Biosciences
Continuity Biosciences is a clinical-stage biotechnology company developing precision drug delivery platforms for the controlled, sustained administration of therapeutics. Its technologies include intratumoral delivery systems for solid tumors, nanofluidic and subcutaneous long-acting implants, implantable devices for cell therapy, and microneedle systems for intradermal delivery. The company’s programs span oncology, type 1 diabetes, endocrinology, HIV prevention, and medical aesthetics. For more information, visit www.continuitybiosciences.com.
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/continuity-biosciences-awarded-9-6-million-grant-to-advance-ultra-long-acting-implant-for-hiv-prevention-302907905.html

14, Oct 2026
IBM and Siemens Collaborate on Research to Advance Nanostack Architecture
Collaboration aims to accelerate development of the manufacturing and design capabilities needed for future nanostack generations
ALBANY, N.Y., Oct. 14, 2026 /PRNewswire/ — Today, IBM (NYSE: IBM), in collaboration with Siemens, announced new research aimed at advancing IBM’s nanostack architecture, a new transistor architecture unveiled by IBM earlier this year. The collaboration will bring together IBM’s leadership in semiconductor device innovation and Siemens’ expertise in electronic design automation (EDA), process simulation, lithography optimization, and advanced manufacturing software to accelerate the development of nanostack.

Nanostack is the industry’s first known three-dimensional, nanosheet-based design, vertically stacking and staggering transistors to pack more transistors onto a chip, with nearly 100 billion transistors in a space the size of a fingernail at its current 7 angstrom node. The design also unlocks the use of different material combinations within each stacked layer to optimize performance and power efficiency of each transistor independent of the other. These innovations power substantial leaps in energy efficiency, performance, and SRAM scaling.
Earlier this year, IBM demonstrated the viability of the nanostack architecture. Now, additional advances are needed to prepare the technology for manufacturing and production at scale.
Through this collaboration, IBM and Siemens will work to advance the design, simulation, and lithography techniques needed for this and future nanostack generations beyond the current 7 angstrom node. The collaboration includes developing advanced virtual models of nanostack in order to model performance, optimize designs, and address fabrication challenges before chips are built.
“Nanostack is a scalable transistor platform designed to shift device scaling from 2D to 3D, representing a new paradigm for the semiconductor industry and a path forward for the logic scaling needed to support AI and other emerging technologies over the coming decade,” said Huiming Bu, Vice President of Silicon Technology R&D, IBM. “We are thrilled to work with Siemens as we continue to advance this technology and explore new approaches to extend angstrom-level scaling with nanostack.”
“Scaling semiconductors into the angstrom era demands tightly coupled co-optimization between device physics, EDA design and manufacturing software, and manufacturing. As physical AI places extraordinary demands on silicon architecture, IBM’s 3D nanostack design represents a pivotal leap forward,” said Ankur Gupta, Executive Vice President, EDA IC Portfolio, Siemens. “Siemens’ collaboration with IBM to advance virtual modeling, simulation, lithography, and design software optimizations needed to address physical limitations early and accelerate the development of these complex architectures is truly pioneering.”
By combining IBM’s semiconductor leadership with Siemens’ advanced EDA software and simulation technologies, the companies aim to accelerate technology development cycles and advance the manufacturing foundation necessary for bringing nanostack toward production.
About IBM
IBM is a leading provider of global hybrid cloud and AI, and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Thousands of governments and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM’s long-standing commitment to trust, transparency, responsibility, inclusivity and service. Visit www.ibm.com for more information.
Media contact:
Willa Hahn
IBM Communications
willa.hahn@ibm.com
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/ibm-and-siemens-collaborate-on-research-to-advance-nanostack-architecture-302907615.html

14, Oct 2026
Spinnaker Support Names Mark Fetches Global Chief Technology Officer
Expanded Role Unites Regional CTOs, Solution Consulting and Technical Account Management in One Global Organization
DENVER, Oct. 14, 2026 /PRNewswire/ — Spinnaker Support, the third-party software support leader entrusted by 1,300+ global clients, today announced the promotion of Mark Fetches to Global Chief Technology Officer (CTO). In the expanded role, Fetches brings the company’s regional CTOs, solution consulting team and technical account managers (TAMs) together into a single global organization. He will report to Chief Revenue Officer Pete Castello and join Spinnaker’s Go-to-Market Leadership Team, strengthening the connection between customer business priorities and Spinnaker’s technical sales and advisory capabilities.

“Customers choose Spinnaker for the expertise of our people,” said Matt Stava, CEO of Spinnaker Support. “Mark showed in EMEA how much customers value close technical engagement from the start. With him leading these teams globally, we can bring that same level of guidance to every region, helping customers solve immediate challenges and plan for what comes next.”
The new structure connects the technical guidance customers receive during evaluation with the expertise they rely on throughout their relationship with Spinnaker. Solution consultants who assess Oracle, SAP, VMware or PostgreSQL environments will now work alongside the TAMs and regional technology leaders who guide customers after the engagement begins. Iain Saunderson, chief technology officer for the Americas, will report to Fetches. Phil Wilkins, technical account manager and enterprise technical architect, and Sree Sakamuri, director of solution consulting, will also join Fetches’ organization.
Fetches previously served as Spinnaker’s CTO for EMEA, where he strengthened technical engagement with clients and connected their business priorities with Spinnaker’s capabilities. He brings more than 30 years of technology consulting and leadership experience from Accenture, Deloitte, and PwC. In those roles, he led customer-facing technical teams and advised C-suite executives and boards on digital, cloud, AI and enterprise transformation programs. Fetches is based in the UK and holds TOGAF and ITIL certifications.
“The best time to talk about modernization is before an upgrade or renewal forces the issue,” said Fetches. “That’s when customers have the greatest freedom to evaluate their options and move forward on their own terms. By bringing together our regional CTOs, solution consultants and technical account managers, we give customers access to the right expertise from the first conversation through execution.”
The promotion comes amid double-digit growth for Spinnaker, as more enterprises turn to independent support for greater control and flexibility. It follows several leadership appointments in 2026, including Rex Young as chief information officer in August and Vivek Pruthi as managing director for APAC. Spinnaker also promoted Martin Biggs to vice president and general manager of its PostgreSQL practice alongside the September launch of new PostgreSQL offerings to help enterprises reduce Oracle database dependency.
Resources:
- When AI Doesn’t Understand Your ERP
- How Madrilena Gas Ensured Stability and Savings with Spinnaker
- How Telkom Turned Oracle Support Savings into Digital Investment
- How a National Telecommunications Provider Stabilized Critical Systems and Reset Its IT Strategy
About Spinnaker Support
Spinnaker Support delivers independent third-party support and expert services for Oracle, SAP, VMware, and PostgreSQL environments. Its support, maintenance and modernization services help organizations run, optimize and transform their enterprise technology environments. It empowers customers to reduce vendor dependency and align technology strategies with business objectives. Spinnaker Support is trusted worldwide, including in highly regulated industries, giving organizations greater choice, control, and flexibility to unlock long-term value and transformation. For more information: www.spinnakersupport.com. Follow Spinnaker on LinkedIn.
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/spinnaker-support-names-mark-fetches-global-chief-technology-officer-302907650.html

14, Oct 2026
Provenir Named a Major Player in the IDC MarketScape: Worldwide Decision Intelligence Platforms 2026 Vendor Assessment
PARSIPPANY, N.J., – October 14, 2026 – Provenir, the Decision Intelligence Platform for financial services providers, on Oct 12 announced it has been positioned in the Major Players Category in the IDC MarketScape: Worldwide Decision Intelligence Platforms 2026 Vendor Assessment (Doc #US54118426, September 2026). Provenir was also named a Major Player in the 2024 edition of this IDC MarketScape.
The recognition follows two years of continued investment in Provenir’s Decision Intelligence Platform, including production-accurate simulation, advances in AI models and assistants, and expanded capabilities designed to help customers design, test and deploy decision strategies faster.
The IDC MarketScape evaluated vendors supporting decision design, decision engineering and decision orchestration. The assessment covered vendors serving industries from financial services and insurance to government, manufacturing, and retail; we believe Provenir earned its position while maintaining a deliberate focus on financial services and adjacent sectors. The 2026 assessment also reflects the growing role of generative and agentic AI in how decision logic is authored, tested and explained, alongside continued human oversight.
The IDC MarketScape highlights Provenir’s unified low-code platform, stating “Provenir brings together decisioning, data orchestration, model orchestration, simulation, and case management in a single cloud-native environment, reducing reliance on separate point solutions for related decisioning functions.”
IDC highlights three areas of strength:
- Unified low-code platform: Provenir brings together decisioning, data orchestration, model orchestration, simulation, and case management in a single cloud-native environment, reducing reliance on separate point solutions for related decisioning functions.
- Breadth of the data marketplace: The vendor’s marketplace includes more than 150 prebuilt integrations with third-party data and analytics providers, and new integrations are typically turned around in about two weeks, shortening timelines that can otherwise stretch to several months.
- Platformwide AI assistant: A generative AI assistant operates across dashboards, model building, and documentation functions platformwide, providing conversational access to insights, recommendations, and translated documentation regardless of which page a user is working from.
The IDC MarketScape also notes Provenir’s “same engine” simulation approach: “where changes are tested using the identical processing rails and up to 12 months of live production data that power the operational platform, which may appeal to organizations that want confidence in projected outcomes before rules or scorecards go live.” This gives organizations greater confidence in projected outcomes before changes go live.
“I believe being named a Major Player for the second assessment in this market reflects the progress we’ve made in building a true decision intelligence platform,” said Lawrence Smith, CEO of Provenir. “Financial services providers need to change strategy quickly without losing control of how decisions are made. By bringing data, AI, simulation and governance together, we help customers test, understand and improve decisions before changes go live.”
Provenir’s generative AI assistant and MCP connectivity are in production today, supporting documentation retrieval, insight generation and guided model building. The IDC MarketScape also notes that Provenir’s near-term road map priorities include “natural language–driven flow generation, expanded automated recommendations, and human-in-the-loop monitoring for agents, reflecting a broader shift from assisted decision design toward continuous, machine learning–informed strategy optimization across the decisioning life cycle.”
To read the IDC MarketScape excerpt featuring Provenir, visit: https://www.provenir.
14, Oct 2026
Nuvei secures license to offer local payment acceptance in South Africa
Expansion into one of Africa’s largest digital commerce markets advances Nuvei’s Every Payment Everywhere strategy, extending its local acquiring infrastructure to 52 markets
MONTREAL, Oct. 14, 2026 /PRNewswire/ — Nuvei, the global fintech building the infrastructure for every payment, everywhere, today announced that it has secured authorization from the Payments Association of South Africa (PASA) to offer local merchant payment services in South Africa, expanding its ability to support global brands and local businesses through its global payments platform.

The authorization advances Nuvei’s Every Payment Everywhere strategy, extending its presence within domestic payment ecosystems to help businesses optimize payment performance in every market they operate. By adding South Africa to its network, Nuvei is extending its local acquiring and payment acceptance infrastructure, transaction data, and operational controls to another major market, accessible through a single global platform.
Phil Fayer, Chair and CEO of Nuvei, said: “Commerce is global, but payment performance is local. Our expansion into South Africa is another step towards giving businesses access to locally optimized payment capabilities at global scale. South Africa is one of Africa’s most important digital commerce markets, and strengthening our presence here creates new opportunities for international businesses entering the region and South African companies expanding globally.”
A growing digital commerce market
South Africa’s B2C ecommerce market grew by an estimated 9.9% in 2025 to reach $8.48 billion, according to research published by PayNXT360. The market is forecast to expand at a compound annual growth rate of 8.3% through 2029, reaching approximately $11.66 billion. This continued growth is increasing the importance of locally optimized payment performance for businesses competing in the market.
Bringing global brands closer to the local market
Processing transactions domestically can improve authorization rates compared with cross-border acquiring, reduce processing costs, and give businesses more complete visibility into transaction performance. Direct access to local transaction data also supports more precise fraud management and enables businesses to identify and address sources of payment friction more effectively.
Global brands entering South Africa will be able to access these capabilities through the same Nuvei integration they use across other markets. Businesses already serving South African consumers cross-border will be able to establish a more locally optimized payments operation without adding a separate gateway, acquiring relationship, and reporting environment. That gives them room to adapt the checkout experience to local expectations while managing authorization, fraud prevention, reconciliation, and reporting through one platform.
About Nuvei
Nuvei is the global fintech building the infrastructure for every payment, everywhere. Its flexible platform supports the full transaction lifecycle, giving the world’s leading companies a single partner for local and cross-border commerce at scale, including the emerging wave of AI-driven agentic commerce. With reach in more than 190 markets, local acquiring in 50+ countries, 150 currencies, and over 720 alternative payment methods, Nuvei brings global infrastructure and local expertise to every market its customers serve.
Learn more at Nuvei.com
Contact:
Public Relations
alex.hammond@nuvei.com
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/nuvei-secures-license-to-offer-local-payment-acceptance-in-south-africa-302908506.html

14, Oct 2026
Oracle NetSuite Announces Launch of AI-first QuickStart: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor.
NEW YORK, Oct. 14, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins.
Kristen Scholer delivers the pre-market update on October 14th
- Oracle NetSuite announces the availability of AI-first financial platform NetSuite QuickStart.
- NetSuite QuickStart is designed for early-stage technology startups.
- Business founders can engage with trusted data in QuickStart via the AI tools they already use, including Claude and ChatGPT.
- Oracle NetSuite Co-founder + EVP Evan Goldberg will join NYSE Live to discuss how QuickStart can help founders elevate their businesses.
- Reflect Orbital announces the purchase of two Skyroot Aerospace launches for future spacecraft.
- By redirecting sunlight from orbit, Reflect aims to extend electricity generation at solar farms and provide light to help search-and-rescue teams find people at night and construction crews work more safely after dark.
- Tune into NYSE Live to hear Co-Founder and CEO Ben Nowack share how it plans to fulfill its mission of delivering sunlight to precise locations on earth.
- BSR Real Estate Investment Trust officially begins trading on the New York Stock Exchange today.
- The company’s portfolio is valued at approximately $1.4 billion, with roughly 90% of net operating income generated from the Texas Triangle markets of Austin, Houston, and Dallas.
- To celebrate its NYSE listing, BSR REIT’s officers and Board of Trustees will ring the Opening Bell at the New York Stock Exchange. It will trade under the ticker BSRT.
- The AUSA Annual Meeting & Exposition concludes today in Washington, D.C.
- More than 40,000 attendees from over 100 countries have come together as they look to shape the future of national security.
- Participating companies include RTX, Boeing, General Dynamics, and Northrop Grumman.
Opening Bell
BSR REIT (NYSE: BSRT) celebrates its first day of trading on the NYSE
Closing Bell
Warburg Pincus celebrates its 60th anniversary
For market insights, IPO activity, and today’s opening bell, download the NYSE TV App and check out the NYSE YouTube: TV.NYSE.com and YouTube.com/@NYSEofficial


View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/oracle-netsuite-announces-launch-of-ai-first-quickstart-nyse-content-update-302908551.html

14, Oct 2026
Workday Launches Autopilot Agents That Get Real Work Done Across HR, Finance, and IT
“Probabilistic AI is great at guessing, but in payroll and finance, a good guess isn’t good enough,” said Gerrit Kazmaier, president, product and technology, Workday. “Our agents can work in the background because they follow the same policies, permissions, and approvals that already run the business. That’s what lets them go beyond making suggestions to anticipate, advise, and act autonomously.”“Until now, AI has worked like a copilot – helpful, but only when you ask it something. That’s not enough anymore,” said Joel Hellermark, chief AI officer, Workday. “Our agents work like autopilots – they get the work done on their own and bring people in exactly when their judgment makes the difference.”
“Agents are moving from singles pickleball – one human and one agent – to an orchestra phase, where the human is the director and agents run in the background, proactively doing the work,” Holger Mueller, vice president and principal analyst, Constellation Research. “Workday’s agents for talent acquisition, payroll, accounting, and more are built for that shift, working as autopilots while people stay in charge.”
14, Oct 2026
Odisha’s New Governor Braj Mohan Ram Puts Jobs, Healthcare and Education on Priority List
Bhubaneswar, Oct 14 (UDN): Newly appointed Odisha Governor Braj Mohan Ram has identified employment, healthcare, education and farmers’ welfare as key areas of focus, saying he will work in coordination with the state government to address public concerns and support Odisha’s development.
Representational Image
Ram is expected to arrive in Odisha shortly to assume office. Speaking to the media following his appointment, he said he would assess the state’s needs through discussions with Chief Minister Mohan Charan Majhi and members of the public before deciding on appropriate steps.
“The duty is to serve the people,” Ram said, emphasising the importance of cooperation and engagement in addressing the state’s challenges.
Jobs, Healthcare and Education in Focus
The incoming Governor highlighted unemployment, access to healthcare and education as major concerns requiring attention. He also stressed the need to listen to farmers and ensure that their issues receive due consideration.
Ram indicated that his approach would involve understanding ground realities and coordinating with the state government to identify ways to address these challenges.
Mineral Wealth Seen as an Opportunity
Referring to Odisha’s abundant mineral resources, Ram said the state’s natural wealth could play an important role in tackling unemployment.
His remarks underscored the potential to use the state’s resources to support economic activity and create employment opportunities, although he did not announce any specific initiative or timeline.
Pledges Cooperation for State’s Development
Ram expressed gratitude to the central leadership and Prime Minister Narendra Modi for entrusting him with the responsibility of Governor.
He said he would engage with the Chief Minister and citizens as required, assess the situation and work towards the state’s progress.
His priorities signal an emphasis on public welfare and cooperation with the elected government as he prepares to take charge as Odisha’s constitutional head.
14, Oct 2026
Lioness Shreya Gives Birth to Cub at Nandankanan; Newborn Under Special Care
Bhubaneswar, Oct 14 (UDN): Asiatic lioness Shreya has given birth to a cub at Nandankanan Zoological Park near Bhubaneswar, but the newborn is currently being raised under specialised care after the first-time mother reportedly failed to accept it.
Representational Image
Shreya, housed in enclosure number 18, delivered a single cub on Tuesday evening, according to reports. As she did not provide maternal care to the newborn, zoo authorities separated the cub from her and shifted it to the infant animal care centre within the veterinary hospital premises.
Experienced animal keepers are now bottle-feeding the cub with diluted milk formula. The newborn is being kept under controlled lighting and monitored as part of its early care.
First-Time Mother Does Not Accept Cub
The birth marked Shreya’s first pregnancy. Reports said the lioness did not show the expected maternal response towards the newborn, prompting zoo officials to intervene to ensure its care and survival.
The cub was born after Shreya mated with Asiatic lion Harsh. Both lions were born on August 29, 2024, to lion Samrat and lioness Bijli, along with another cub, Dhruv. As Shreya and Harsh are siblings, the newborn is the result of inbreeding.
Concerns Over Cub Survival
The latest birth comes amid concerns over the survival of lion cubs born through closely related pairings at the zoo.
Last month, lioness Maya gave birth to two cubs following mating with Shivam, who is also her litter-mate. One cub was stillborn, while the other, a male, died four days after birth while receiving veterinary care, according to the report.
The recent cases highlight the challenges involved in raising newborn lion cubs at Nandankanan, particularly when maternal care is absent or the cubs face additional risks.
Newborn Receives Intensive Care
With Shreya not caring for her cub, the immediate focus remains on providing appropriate feeding and a controlled environment for the newborn. Its long-term survival will depend on its condition and response to the care being provided.
Zoo authorities are continuing to care for the cub at the infant animal care centre. No further details about its current health condition or long-term prospects were available in the report.